Other studies have shown that metformin synergistically enhances the cytotoxic effect of imatinib (tyrosine kinase inhibitor) [39] as well as BEZ235 (an experimental dual inhibitor of PI3K and mTOR kinases) [40] in colon cancer cells. The gene discussed is MTOR; the disease is malignant colon neoplasm.